MSC - Page 23

Can Regenerative Medicine Help Manage Neurodegenerative Conditions?

Neurodegenerative conditions such as Alzheimer’s disease (AD), stem cell therapy for Parkinson disease’s disease (PD), and amyotrophic lateral sclerosis (ALS) occur when neuron populations begin to diminish. There is currently no cure for these types of diseases, though clinical trials to explore various treatment options are ongoing. In particular, regenerative medicine, also known as regenerative…

Stem Cells For Autoimmune Diseases: MSCs

For decades, autoimmune diseases such as Lupus, regenerative medicine for rheumatoid arthritis, and chronic obstructive pulmonary disease (COPD) have posed a major challenge to researchers and healthcare providers. While medical interventions have evolved tremendously in the last few decades, these serious conditions remain notoriously difficult to treat. Here we talk about Stem Cell for stem…

Stem Cells Can Help Patients With MS

As one of the most common neurodegenerative disorders, multiple sclerosis (MS) affects millions of patients. This progressive condition can cause everything from muscle weakness to double vision. Regenerative medicine is showing new potential when it comes to treating multiple sclerosis. Read on to learn more about how stem cells can help patients with MS. What…

Physical Therapy for Pain Management

Up to 50 million Americans suffer from chronic or long-term pain. Missing work, the inability to do recreational activities, lack of concentration, and poor mental health are all side effects of living with chronic pain. However, one of the last things pain sufferers want to do may be the most effective treatment for chronic pain: exercise,…

Efficacy of DMSA and EDTA in Chelation of Toxic Metals and Improvement of the Number of Stem Cells in Circulation

Metal toxicity, resulting from lead, mercury, aluminum, and arsenic, continues to be a significant public health concern and contributes to a number of serious health issues, including damage to the central and peripheral nervous systems, compromised kidney and liver function, and damage to the cardiovascular system.  Specifically, toxic metals appear to contribute to oxidative stress…

Safety and Clinical Outcomes In Chronic Ischemic Stroke Patients After Implantation of Mesenchymal Stem Cells

According to the CDC, stroke continues to be a major cause of serious disability for adults. It is also estimated that nearly 800,000 people in the United States have a stroke each year[1]. While 80% of those experiencing a stroke survive for at least one year following the event, more than 70% will continue to…

Evaluating Stem Cells As A Treatment Option For Kidney Disease

Current estimates indicate that kidney disease currently affects over 37 million US adults and over 10% of the global population[1]. Characterized by gradual loss of function, kidney disease generally progresses over time and culminates in the inability to remove waste and excess fluid from the blood[2].   Often demonstrating little to no symptoms in its early…

The Efficacy Of Wharton’s Jelly Mesenchymal Stem Cells For Treating Type 2 Diabetes

According to recent data from the CDC, an estimated 30 million Americans currently have type 2 diabetes mellitus (T2DM), and another 88 million are considered to be prediabetic[1].  Occurring most often as a result of being overweight and/or sedimentary and often resulting in severe kidney, heart, or vision issues, T2DM has demonstrated to be difficult…

Using Mesenchymal Stem Cells In The Repair Of Articular Cartilage

Articular cartilage is the smooth, white cartilage that covers the ends of the bone in diarthrodial joints. Essential for fluid and pain-free movement, articular cartilage protects the bones by reducing friction and absorbing shock. However, articular cartilage is also subject to damage and injury as a result of normal wear and tear or as a…

Using Autologous Adipose-Derived Stem Cells and Platelet-Rich Plasma to Treat Symptomatic Knee Osteoarthritis

stem cell therapy for osteoarthritis is the most common form of arthritis, affecting more than 900 million people around the world. Developing when the cartilage that protects your bones wears down, osteoarthritis (OA) most commonly affects the joints of the hand, hips, spine, and knees[1]. While current treatment for OA and related joint damage is…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.